Analyst firms · H.C. Wainwright · VSTM
H.C. Wainwright VSTM price target and rating history
Verastem Inc. (VSTM) · Health Care
H.C. Wainwright rates Verastem Inc. (VSTM) Buy with a $18 price target, as of its latest action on Feb 4, 2026. It has published 3 rating actions on VSTM since July 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $18
- Median target, all firms
- Too few
- Actions on VSTM
- 3
H.C. Wainwright price target on VSTM
Every H.C. Wainwright rating on VSTM
- Feb 4, 2026
- Mar 24, 2025
- Jul 20, 2021
How other firms rate VSTM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wolfe Research | Outperform | Sep 17, 2026 | |
| BTIG | Buy | $19 | Mar 12, 2026 |
| H.C. Wainwright | Buy | $18 | Feb 4, 2026 |
Questions about H.C. Wainwright and VSTM
- What is H.C. Wainwright's price target for VSTM?
- H.C. Wainwright's latest stated price target for Verastem Inc. (VSTM) is $18, from its action on Feb 4, 2026.
- What is H.C. Wainwright's rating on VSTM?
- H.C. Wainwright rates VSTM Buy, a bullish rating, as of Feb 4, 2026.
- When did H.C. Wainwright last change its view on VSTM?
- On Feb 4, 2026, H.C. Wainwright starts coverage at Buy, price target $18.
More VSTM rating histories
All H.C. Wainwright ratingsVSTM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.